FIELD: medicine.
SUBSTANCE: invention relates to medicine, to radiation diagnostics, can be used to determine abstinence non-compliance in alcoholic liver disease. Diffusion-weighted images (DWIs) of the liver are obtained in magnetic resonance imaging. A qualitative assessment of diffusion is conducted: the white color scale corresponds with diffusion restriction, the black color scale corresponds with no diffusion restriction. The presence of diffusion restriction indicates abstinence non-compliance. The absence of diffusion restriction indicates the absence of the abstinence non-compliance.
EFFECT: method ensures an expansion in the range of methods for determining abstinence non-compliance due to a qualitative assessment of diffusion.
1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS, HEPATITIS, ALCOHOLIC CIRRHOSIS | 2020 |
|
RU2741698C1 |
| METHOD FOR DIAGNOSTICS OF VIRAL, ALCOHOLIC, VIRAL AND ALCOHOLIC ETIOLOGY OF DIFFUSED LIVER DISEASES BOTH WITHOUT PROGRESSION AND WITH PROGRESSION | 2022 |
|
RU2792320C1 |
| METHOD FOR NON-INVASIVE DIAGNOSTICS OF MORPHOFUNCTIONAL DISORDERS IN SPLEEN WITH PORTAL HYPERTENSION | 2022 |
|
RU2815256C1 |
| METHOD OF DIAGNOSTICS OF LIVER STEATOSIS | 2017 |
|
RU2648183C1 |
| METHOD FOR PREDICTING AETIOLOGY OF SIALOADENITIS IN PATIENTS WITH CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2023 |
|
RU2806122C1 |
| METHOD FOR PREDICTION OF HEMOSTASIS DISORDERS IN PATIENTS WITH DIFFUSED LIVER DISEASES | 2022 |
|
RU2784466C1 |
| METHOD FOR PREDICTING THE OUTCOME OF CIRRHOSIS IN HEPATIC CANCER CIRRHOSIS | 2020 |
|
RU2741691C1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF DIFFUSE LIVER DISEASES | 2020 |
|
RU2737499C1 |
| METHOD FOR VERIFICATION OF SYMPTOMATIC AND MINIMAL HEPATIC ENCEPHALOPATHY IN CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2022 |
|
RU2792568C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PORTAL HYPERTENSION IN DIFFUSE LIVER DISEASES | 2020 |
|
RU2741369C1 |
